{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:08:39Z","timestamp":1749182919391,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,5]]},"DOI":"10.7759\/cureus.85414","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:48:08Z","timestamp":1749138488000},"source":"Crossref","is-referenced-by-count":0,"title":["Guillain-Barr\u00e9 Syndrome Associated With COVID-19 Infection: A Case Report and Review of Pathophysiology, Risk Factors, and Management"],"prefix":"10.7759","author":[{"given":"Ryan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Samavati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec J","family":"Lippmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"CDC museum COVID-19 timeline. (2024). Accessed. April 8, 2025: https:\/\/www.cdc.gov\/museum\/timeline\/covid19.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta A","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, 26:1017-32. 10.1038\/s41591-020-0968-3","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1396642","article-title":"Guillain-Barre syndrome and link with COVID-19 infection and vaccination: a review of literature","volume":"15","author":"Valaparla VL","year":"2024","unstructured":"Valaparla VL, Rane SP, Patel C, Li X. Guillain-Barre syndrome and link with COVID-19 infection and vaccination: a review of literature. Front Neurol. 2024, 15:1396642. 10.3389\/fneur.2024.1396642","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto M","year":"2021","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, et al.. Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021, 92:751-6. 10.1136\/jnnp-2020-324837","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref7","unstructured":"Cerebrospinal fluid (CSF) collection. (2023). Accessed. April 2, 2025: https:\/\/www.ucsfhealth.org\/medical-tests\/cerebrospinal-fluid-(csf)-collection."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100738","article-title":"COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics","volume":"37","author":"Azer SA","year":"2020","unstructured":"Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect. 2020, 37:100738. 10.1016\/j.nmni.2020.100738","journal-title":"New Microbes New Infect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Guti\u00e9rrez-Ortiz C","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez-Guerrero A, Rodrigo-Rey S, et al.. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020, 95:601-5. 10.1212\/WNL.0000000000009619","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.947416","article-title":"Post-COVID-19 Guillain-Barr\u00e9 syndrome with GM1 and GD1b antibodies: a case study and literature review","volume":"26","author":"Thiriveedi M","year":"2025","unstructured":"Thiriveedi M, Sto Domingo FG, Longley S, Patel S, Baddam S, Chimakurthy A. Post-COVID-19 Guillain-Barr\u00e9 syndrome with GM1 and GD1b antibodies: a case study and literature review. Am J Case Rep. 2025, 26:947416. 10.12659\/AJCR.947416","journal-title":"Am J Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh S","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021, 268:1133-70. 10.1007\/s00415-020-10124-x","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref13","unstructured":"Guillain-Barre syndrome risk factors. (2024). Accessed. April 16, 2025: https:\/\/ameripharmaspecialty.com\/guillain-barre-syndrome\/guillain-barre-syndrome-risk-factors\/."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061248","article-title":"The impact of COVID-19 on the Guillain-Barr\u00e9 syndrome incidence","volume":"12","author":"Kopa\u0144ko M","year":"2024","unstructured":"Kopa\u0144ko M, Zab\u0142udowska M, Zajkowska M, Gudowska-Sawczuk M, Mucha M, Mroczko B. The impact of COVID-19 on the Guillain-Barr\u00e9 syndrome incidence. Biomedicines. 2024, 12:1248. 10.3390\/biomedicines12061248","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usab158","article-title":"Guillain-Barre syndrome associated with COVID-19 pneumonia-the first documented case in a U.S. military intensive care unit","volume":"188","author":"Yiu AC","year":"2023","unstructured":"Yiu AC, Hussain A, Okonkwo UA, Villacorta-Lyew R, McMahon MJ, Blattner M. Guillain-Barre syndrome associated with COVID-19 pneumonia-the first documented case in a U.S. military intensive care unit. Mil Med. 2023, 188:852-6. 10.1093\/milmed\/usab158","journal-title":"Mil Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/ctn6010007","article-title":"Hot topics on COVID-19 and its possible association with Guillain-Barr\u00e9 syndrome","volume":"6","author":"Dietmann A","year":"2022","unstructured":"Dietmann A, Ripellino P, Humm AM, Hundsberger T, Schreiner B, Th\u00e9audin M, Scheidegger O. Hot topics on COVID-19 and its possible association with Guillain-Barr\u00e9 syndrome. Clin Transl Neurosci. 2022, 6:7. 10.3390\/ctn6010007","journal-title":"Clin Transl Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674922","article-title":"SARS-CoV-2 infection and Guillain-Barr\u00e9 syndrome: a review on potential pathogenic mechanisms","volume":"12","author":"Shoraka S","year":"2021","unstructured":"Shoraka S, Ferreira ML, Mohebbi SR, Ghaemi A. SARS-CoV-2 infection and Guillain-Barr\u00e9 syndrome: a review on potential pathogenic mechanisms. Front Immunol. 2021, 12:674922. 10.3389\/fimmu.2021.674922","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000342","article-title":"Treatment options for COVID-19-related Guillain-Barr\u00e9 syndrome: a systematic review of literature","volume":"26","author":"Goudarzi S","year":"2021","unstructured":"Goudarzi S, Esmaeeli S, Valencia JD, et al.. Treatment options for COVID-19-related Guillain-Barr\u00e9 syndrome: a systematic review of literature. Neurologist. 2021, 26:196-224. 10.1097\/NRL.0000000000000342","journal-title":"Neurologist"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the quality standards subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes RA","year":"2003","unstructured":"Hughes RA, Wijdicks EF, Barohn R, et al.. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2003, 61:736-40. 10.1212\/wnl.61.6.736","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207900","article-title":"Association between Guillain-Barr\u00e9 syndrome and COVID-19 infection and vaccination: a population-based nested case-control study","volume":"101","author":"Bishara H","year":"2023","unstructured":"Bishara H, Arbel A, Barnett-Griness O, et al.. Association between Guillain-Barr\u00e9 syndrome and COVID-19 infection and vaccination: a population-based nested case-control study. Neurology. 2023, 101:2035-42. 10.1212\/WNL.0000000000207900","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/371804-guillain-barr-syndrome-associated-with-covid-19-infection-a-case-report-and-review-of-pathophysiology-risk-factors-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:48:09Z","timestamp":1749138489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/371804-guillain-barr-syndrome-associated-with-covid-19-infection-a-case-report-and-review-of-pathophysiology-risk-factors-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.85414","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}